ALLIANCE PHARMA PLC

AGM Information • Apr 10, 2014

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4823E

Alliance Pharma PLC

10 April 2014

For immediate release	10 April 2014

ALLIANCE PHARMA PLC

(the "Company")

Annual Report and AGM Notice

Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, is pleased to announce that its 2013 Annual Report and Accounts and Notice of Annual General Meeting, which will be held on 21 May 2014, are now available on the Company's website at www.alliancepharma.co.uk

Printed copies of both documents will be posted to shareholders shortly and may also be requested by email at ir@alliancepharma.co.uk.

For further information:

### Alliance Pharma plc	### + 44 (0) 1249 466966
John Dawson, Chief Executive
Richard Wright, Finance Director
www.alliancepharma.co.uk
### Buchanan	### + 44 (0) 20 7466 5000
Mark Court / Fiona Henson / Sophie Cowles
Numis Securities Limited	+ 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Oliver Cardigan / Freddie Barnfield
Corporate Broking: David Poutney

Notes to editors:

About Alliance

Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCILMFTMBTMBPI